Comprehensive Index of National Vaccine Injury Compensation Program Cases ← all cases Home Firms Attorneys Stats Special Masters About Us

Sol P. Ajalat — Petitioner Attorney, U.S. Vaccine Court

Petitioner attorney U.S. Court of Federal Claims · Office of Special Masters Last verified
Cases filed
6
Comp rate
33%
Total awarded
$284K
Years active
2014–2023
FirmsAjalat & Ajalat, LLP (6)
Heads up: The case docket, statistics, and overview below are compiled from AI-extracted data. Specific figures (case counts, awards, outcomes) may contain errors. Verify with the attorney directly or with source court records before relying on them.

About Sol P. Ajalat

Sol Peter Ajalat (1932–2023) was the founding partner of Ajalat & Ajalat, LLP in Los Angeles and a pioneer of vaccine injury litigation. A 1958 UCLA graduate (B.A., Public Health Administration) and a 1962 UCLA School of Law J.D., he was the first U.S. attorney to sue Merck over the Gardasil HPV vaccine, an action that forced production of millions of internal documents and resulted in 16 federal cases proceeding to trial as exemplars; he practiced for more than 60 years until his death in June 2023.

AI-generated overview · may contain errors. Verify details with the attorney directly before relying on them.
Sources: [1]

VICP practice summary

Sol P. Ajalat is a petitioner attorney with the U.S. Court of Federal Claims, Office of Special Masters, who has filed 6 petitions in the National Vaccine Injury Compensation Program (VICP) between 2014 and 2023. Cases filed by Sol P. Ajalat have resulted in $284K in total compensation awards (33% compensation rate across all petitions). Practice has been associated with Ajalat & Ajalat, LLP.

Frequently asked questions about Sol P. Ajalat

Answers built from this attorney's public case docket.

How do I find a good VICP lawyer?
Most petitioners hire counsel because the program's evidentiary burden, expert-witness requirements, and procedural rules are complex. Reasonable attorney fees in VICP cases are paid by the program — not by the petitioner — under 42 U.S.C. § 300aa-15(e)(1), so engaging counsel does not reduce a successful petitioner's recovery. Browse this index to research individual attorneys' case histories.
Who is Sol P. Ajalat?
Sol P. Ajalat is a petitioner attorney with the U.S. Court of Federal Claims, Office of Special Masters, who represents petitioners in the National Vaccine Injury Compensation Program (VICP). The VICP Registry shows 6 petitions filed by Sol P. Ajalat between 2014 and 2023.
How many VICP cases has Sol P. Ajalat filed?
Sol P. Ajalat has filed 6 petitions in the National Vaccine Injury Compensation Program according to the VICP Registry. Of these, 2 resulted in compensation, for an overall compensation rate of 33%.
What is Sol P. Ajalat's VICP compensation rate?
Sol P. Ajalat's overall compensation rate across all VICP petitions is 33% (2 compensated cases out of 6 total).
What is the total amount awarded in cases filed by Sol P. Ajalat?
Cases filed by Sol P. Ajalat have resulted in $284K in total compensation awards from the U.S. Vaccine Injury Compensation Program. This figure reflects only awards visible in published Court of Federal Claims decisions; settlements with non-public terms are not included.
What law firm is Sol P. Ajalat associated with?
Sol P. Ajalat has been associated with Ajalat & Ajalat, LLP in cases filed under the National Vaccine Injury Compensation Program.
FiledDecidedPetitionerAttorneyFirm Age at VaccinationVaccineCondition OutcomeSpecial MasterAward
2017-04-102023-05-31Berlin BravoSol P. AjalatAjalat & Ajalat, LLP14.0yHPVmultiple sclerosisdeniedChristian J. Moran–
2018-07-192019-12-30Devon Nicole IngberSol P. AjalatAjalat & Ajalat, LLP17.0yhuman papillomavirusPostural Orthostatic Tachycardia Syndrome (POTS) and TransvedismissedNora Beth Dorsey–
2011-02-072015-07-10Sherril K. StillwellSol P. AjalatAjalat & Ajalat53.0yinfluenzaacute demyelinating encephalomyelitis (ADEM)deniedLisa D. Hamilton-Fieldman–
2013-09-252015-06-26Jennifer RobiSol P. AjalatAjalat & Ajalat–human papillomavirusacquired demyelination neuropathy or an aggravation of existdeniedChristian J. Moran–
2014-01-072014-09-23Kim Eileen RichSol P. AjalatAjalat & Ajalat, LLP–Tdapacquired demyelinating neuropathy, likely Guillain Barre SyncompensatedThomas L. Gowen$133,617
2013-05-022014-04-04Brian Charles JensenSol P. AjalatAjalat & Ajalat, LLP–TdapDemyelinating Sensorimotor PolyneuropathycompensatedChristian J. Moran$150,000